According to MarketsandMarketsâ„¢, the Lateral Flow Assays Market is projected to reach USD 13.52 billion by 2031 from USD 9.14 billion in 2026, at a CAGR of 8.1% during the forecast period.
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Lateral Flow Assay Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, ...
SHERIDAN, Wyo., Sept. 22, 2026 /PRNewswire/ -- The global lateral flow assay market is projected to grow from USD 11.04 billion in 2026 to USD 16.37 billion by 2031, registering a CAGR of 8.2% during ...
Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.
Intelligent Bio Solutions expects a sixth U.S. patent for its innovative non-invasive drug testing technology, enhancing market entry plans. Intelligent Bio Solutions Inc. (INBS), a medical technology ...
Cannabix Technologies Inc. filed a provisional patent application in the United States covering a novel rapid point-of-care ("POCT") marijuana breath test method designed to detect delta-9 ...